The Melbourne-based digital health firm has been named preferred supplier for one of the NHS’s largest acute trusts.
Australian digital health company Alcidion has been selected as the preferred supplier for a new electronic patient record system at one of the United Kingdom’s largest hospital networks, in a deal expected to be worth more than $AU35 million.
The Melbourne-based group has been chosen by the University Hospitals Sussex NHS Foundation Trust following a competitive tender process.
The trust is part of the Sussex Integrated Care System and provides hospital and community health services to around one million people across the south of England.
One of the UK’s largest acute trusts, it operates seven hospitals and supports more than 1.5 million outpatient appointments, emergency department presentations and surgical cases each year, with a workforce of almost 20,000 staff.
Under the proposed agreement, Alcidion will deploy its flagship Miya Precision electronic patient record platform, including Miya Observations and Assessments, also known as Patientrack, which is already in use at the trust.
The expanded EPR solution is designed to deliver real-time access to patient records, support improved patient flow and strengthen clinical decision-making across hospital and community settings. Subject to final contract execution, deployment of Miya Precision is expected to commence in the fourth quarter of the 2026 financial year.
Writing on LinkedIn, the trust’s chief strategy officer, Roxanne Smith, said reaching the preferred supplier stage marked a significant milestone for the organisation.
“Reaching this point is a big achievement for an organisation of our size and complexity,” she said.
“More than 1500 staff helped shape what we need from an electronic patient record, and a further 150 were involved in selecting the right solution. That level of involvement reflects how strongly our teams feel about getting this right.
“Our patients are at the centre of every decision we make, and moving to a single electronic patient record will have a real impact on safety, quality of care and outcomes. For a large, busy trust caring for communities across Sussex, moving from analogue to digital is essential if we are to deliver excellent care everywhere.
Related
“The EPR is a cornerstone of our trust strategy. It will help us share information more securely and efficiently across our hospitals and with partners such as GPs and mental health services, reducing duplication, improving consistency and supporting better joined-up care for our communities.”
Alcidion’s managing director Kate Quirke said the move built on the company’s long-standing relationship with University Hospitals Sussex.
“We are excited to have been selected by UHSx as their preferred EPR supplier. This builds on a long-standing relationship Alcidion have with UHSx where they have been using Miya Observations and Assessments (Patientrack) for many years,” she said.
“UHSx’s purpose for the EPR procurement is to implement a single, integrated digital platform that improves patient care, supports regional integration, drives operational efficiency and delivers long-term social and research benefits.
“Miya Precision is ideally placed to deliver on this vision, working alongside the implementation teams and clinical staff at UHSx to ensure there is long term benefit to the people of this region.”
For the Australian digital health sector, the announcement further strengthens Alcidion’s position in international markets, particularly within the UK’s National Health Service.
Since listing on the ASX in 2016, the company has expanded its footprint across the UK, Australia and New Zealand, now supporting more than 400 hospitals and 87 healthcare organisations, with further geographic expansion planned.